168 related articles for article (PubMed ID: 10704151)
1. Cell cycle regulation and RNA polymerase II.
Bregman DB; Pestell RG; Kidd VJ
Front Biosci; 2000 Feb; 5():D244-57. PubMed ID: 10704151
[TBL] [Abstract][Full Text] [Related]
2. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control.
Oelgeschläger T
J Cell Physiol; 2002 Feb; 190(2):160-9. PubMed ID: 11807820
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
Guo Z; Stiller JW
BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
[TBL] [Abstract][Full Text] [Related]
4. TFIIF-associating carboxyl-terminal domain phosphatase dephosphorylates phosphoserines 2 and 5 of RNA polymerase II.
Lin PS; Dubois MF; Dahmus ME
J Biol Chem; 2002 Nov; 277(48):45949-56. PubMed ID: 12351650
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
Serizawa H
J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
[TBL] [Abstract][Full Text] [Related]
6. Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity.
Edwards MC; Wong C; Elledge SJ
Mol Cell Biol; 1998 Jul; 18(7):4291-300. PubMed ID: 9632813
[TBL] [Abstract][Full Text] [Related]
7. FCP1 phosphorylation by casein kinase 2 enhances binding to TFIIF and RNA polymerase II carboxyl-terminal domain phosphatase activity.
Palancade B; Dubois MF; Bensaude O
J Biol Chem; 2002 Sep; 277(39):36061-7. PubMed ID: 12138108
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation independent of TFIIH kinase and the RNA polymerase II mediator in vivo.
Lee D; Lis JT
Nature; 1998 May; 393(6683):389-92. PubMed ID: 9620805
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation state of the RNA polymerase II C-terminal domain (CTD) in heat-shocked cells. Possible involvement of the stress-activated mitogen-activated protein (MAP) kinases.
Venetianer A; Dubois MF; Nguyen VT; Bellier S; Seo SJ; Bensaude O
Eur J Biochem; 1995 Oct; 233(1):83-92. PubMed ID: 7588777
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.
Tamrakar S; Kapasi AJ; Spector DH
J Virol; 2005 Dec; 79(24):15477-93. PubMed ID: 16306619
[TBL] [Abstract][Full Text] [Related]
11. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.
Ramanathan Y; Rajpara SM; Reza SM; Lees E; Shuman S; Mathews MB; Pe'ery T
J Biol Chem; 2001 Apr; 276(14):10913-20. PubMed ID: 11278802
[TBL] [Abstract][Full Text] [Related]
12. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases.
Rickert P; Corden JL; Lees E
Oncogene; 1999 Jan; 18(4):1093-102. PubMed ID: 10023686
[TBL] [Abstract][Full Text] [Related]
13. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.
Gold MO; Rice AP
Nucleic Acids Res; 1998 Aug; 26(16):3784-8. PubMed ID: 9685496
[TBL] [Abstract][Full Text] [Related]
14. Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1.
Rossi DJ; Londesborough A; Korsisaari N; Pihlak A; Lehtonen E; Henkemeyer M; Mäkelä TP
EMBO J; 2001 Jun; 20(11):2844-56. PubMed ID: 11387217
[TBL] [Abstract][Full Text] [Related]
15. The sensitivity of RNA polymerase II in elongation complexes to C-terminal domain phosphatase.
Lehman AL; Dahmus ME
J Biol Chem; 2000 May; 275(20):14923-32. PubMed ID: 10809737
[TBL] [Abstract][Full Text] [Related]
16. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
Devaiah BN; Singer DS
J Biol Chem; 2012 Nov; 287(46):38755-66. PubMed ID: 23027873
[TBL] [Abstract][Full Text] [Related]
18. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.
Gold MO; Tassan JP; Nigg EA; Rice AP; Herrmann CH
Nucleic Acids Res; 1996 Oct; 24(19):3771-7. PubMed ID: 8871557
[TBL] [Abstract][Full Text] [Related]
19. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
